Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
May 23, 2025, 4:00 PM EDT
Altamira Therapeutics Employees
Altamira Therapeutics had 11 employees as of December 31, 2024. The number of employees increased by 1 or 8.65% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
8.65%
Revenue / Employee
n/a
Profits / Employee
-$768,886
Market Cap
571.55K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
American Oncology Network | 1,914 |
Altamira Therapeutics News
- 24 days ago - Altamira Therapeutics Ltd. (CYTOF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025 - GlobeNewsWire
- 2 months ago - Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent - GlobeNewsWire
- 5 months ago - Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA - GlobeNewsWire
- 5 months ago - Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets - GlobeNewsWire
- 8 months ago - Altamira Therapeutics Provides Update on Nasdaq Listing - GlobeNewsWire
- 8 months ago - Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray - GlobeNewsWire